FIG. 1.

Characteristics of women not categorized as responders to treatment. Percentages of women by treatment and response criteria. Nonresponders were defined as women who did not simultaneously meet both primary end point bleeding criteria (<80 mL MBL and ≥50% reduction from baseline in MBL at final month) or women who simultaneously met both primary end point bleeding criteria (<80 mL MBL and ≥50% reduction from baseline MBL at final month) but prematurely discontinued treatment because of AEs or lack of efficacy or required surgical or invasive fibroid treatment. AEs, adverse events; MBL, menstrual blood loss.